|
1
|
Metabolic pathways
|
hsa01100
|
279
|
7.43 × 10− 22
|
|
2
|
Complement and coagulation cascades
|
hsa04610
|
44
|
5.74 × 10−14
|
|
3
|
Proteoglycans in cancer
|
hsa05205
|
58
|
4.17 × 10−8
|
|
4
|
Pathways in cancer
|
hsa05200
|
87
|
3.72 × 10−7
|
|
5
|
Insulin resistance
|
hsa04931
|
33
|
1.08 × 10−5
|
|
6
|
Carbon metabolism
|
hsa01200
|
33
|
1.46 × 10−5
|
|
7
|
Axon guidance
|
hsa04360
|
44
|
2.23 × 10−5
|
|
8
|
Ras signaling pathway
|
hsa04014
|
52
|
3.77 × 10−5
|
|
9
|
Glycine, serine and threonine metabolism
|
hsa00260
|
17
|
4.59 × 10−5
|
|
10
|
Mineral absorption
|
hsa04978
|
19
|
8.74 × 10−5
|
|
11
|
PPAR signaling pathway
|
hsa03320
|
23
|
1.08 × 10−4
|
|
12
|
Wnt signaling pathway
|
hsa04310
|
35
|
1.53 × 10− 4
|
|
13
|
Transcriptional misregulation in cancer
|
hsa05202
|
41
|
1.72 × 10−4
|
|
14
|
AGE-RAGE signaling pathway in diabetic complications
|
hsa04933
|
28
|
1.74 × 10−4
|
|
15
|
HIF-1 signaling pathway
|
hsa04066
|
28
|
2.28 × 10−4
|
|
16
|
mTOR signaling pathway
|
hsa04150
|
36
|
3.31 × 10−4
|
|
17
|
Fatty acid metabolism
|
hsa01212
|
17
|
3.32 × 10−4
|
|
18
|
Focal adhesion
|
hsa04510
|
44
|
3.81 × 10−4
|
|
19
|
Regulation of actin cytoskeleton
|
hsa04810
|
46
|
3.91 × 10−4
|
|
20
|
Fatty acid degradation
|
hsa00071
|
16
|
3.94 × 10−4
|
|
21
|
Steroid hormone biosynthesis
|
hsa00140
|
19
|
3.94 × 10−4
|
|
22
|
Bile secretion
|
hsa04976
|
21
|
4.29 × 10−4
|
|
23
|
Aldosterone-regulated sodium reabsorption
|
hsa04960
|
15
|
4.65 × 10−4
|
|
24
|
Jak-STAT signaling pathway
|
hsa04630
|
36
|
5.50 × 10−4
|
|
25
|
ErbB signaling pathway
|
hsa04012
|
24
|
6.18 × 10−4
|
|
26
|
Steroid biosynthesis
|
hsa00100
|
10
|
6.33 × 10−4
|
|
27
|
Valine, leucine and isoleucine degradation
|
hsa00280
|
16
|
7.02 × 10−4
|
|
28
|
Renal cell carcinoma
|
hsa05211
|
20
|
7.19 × 10−4
|
|
29
|
Biosynthesis of amino acids
|
hsa01230
|
21
|
9.01 × 10−4
|
|
30
|
Tyrosine metabolism
|
hsa00350
|
13
|
9.74 × 10−4
|
|
31
|
Tryptophan metabolism
|
hsa00380
|
14
|
1.01 × 10−3
|
|
32
|
EGFR tyrosine kinase inhibitor resistance
|
hsa01521
|
22
|
1.09 × 10−3
|
|
33
|
Cytokine-cytokine receptor interaction
|
hsa04060
|
51
|
1.10 × 10−3
|
|
34
|
Arginine biosynthesis
|
hsa00220
|
10
|
1.11 × 10− 3
|
|
35
|
Proximal tubule bicarbonate reclamation
|
hsa04964
|
10
|
1.45 × 10−3
|
|
36
|
Sphingolipid metabolism
|
hsa00600
|
15
|
1.46 × 10−3
|
|
37
|
Rap1 signaling pathway
|
hsa04015
|
43
|
1.48 × 10−3
|
|
38
|
Hippo signaling pathway-multiple species
|
hsa04392
|
11
|
1.64 × 10−3
|
|
39
|
FoxO signaling pathway
|
hsa04068
|
30
|
1.79 × 10−3
|
|
40
|
Glycerolipid metabolism
|
hsa00561
|
17
|
1.84 × 10−3
|
|
41
|
Vitamin digestion and absorption
|
hsa04977
|
10
|
1.87 × 10−3
|
|
42
|
Pentose phosphate pathway
|
hsa00030
|
11
|
2.05 × 10−3
|
|
43
|
cAMP signaling pathway
|
hsa04024
|
40
|
2.13 × 10−3
|
|
44
|
AMPK signaling pathway
|
hsa04152
|
28
|
2.26 × 10−3
|
|
45
|
Arginine and proline metabolism
|
hsa00330
|
15
|
2.41 × 10−3
|
|
46
|
Alanine, aspartate and glutamate metabolism
|
hsa00250
|
12
|
2.60 × 10−3
|
|
47
|
Epithelial cell signaling in Helicobacter pylori infection
|
hsa05120
|
18
|
3.00 × 10−3
|
|
48
|
beta-Alanine metabolism
|
hsa00410
|
11
|
3.13 × 10−3
|
|
49
|
Insulin signaling pathway
|
hsa04910
|
30
|
3.13 × 10−3
|
|
50
|
Propanoate metabolism
|
hsa00640
|
11
|
3.81 × 10−3
|
